HighVista Strategies’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-76,021
| Closed | -$2.92M | – | 169 |
|
|
2023
Q2 | $2.92M | Buy |
76,021
+26,526
| +54% | +$1.02M | 1.34% | 20 |
|
|
2023
Q1 | $1.15M | Hold |
49,495
| – | – | 0.93% | 31 |
|
|
2022
Q4 | $1.3M | Sell |
49,495
-34,056
| -41% | -$892K | 0.77% | 34 |
|
|
2022
Q3 | $1.64M | Buy |
83,551
+32,717
| +64% | +$643K | 0.94% | 33 |
|
|
2022
Q2 | $889K | Sell |
50,834
-16,943
| -25% | -$296K | 0.54% | 41 |
|
|
2022
Q1 | $1.11M | Buy |
+67,777
| New | +$1.11M | 0.71% | 31 |
|